Biopure

CMAV Case Study Preparation Questions
Biopure

**********************************************************************
Please type the following statement in to your assignment when submitting it:“I attest that I have not received assistance or information about this case or the study questions from any other person or resource (except Kate). Furthermore, I attest that I have not providedassistance or information about this case to any other student in the class.”

*********************************************************************
Use the lecture slides from Sessions 1, 2, 3,4 to help guide your thinking on these questions. Submit written answers to questions 1-5 below. Submit via email attachment using the proper file name on the attachment, i.e.,STC382_LastNameFirstInitial_BiopureQuestions

1. What is Biopure’s potential in the human and animal markets? That is:

a. What is the per year market potential, in units and dollars, for the human market?Human.-
150000(capacity to produce) X800 (estimated price)= 12000000-
4950000(estimated produce cost per year) =1150050000- 4950 (base product)=
1150045050
Units full capacity= 150000 increasing 66% of 90% of the traumatic cases
The result is 1,150,045,050 at800 per unit

Note: The produce cost per year is for Hemorope 33% and Oxylobin 67%

b. What is the per year market potential, in units and dollars, for the animal market?
Animals.208593(Potencial units sales)x100 (estimated price)=20859300-10050000(estimated produce cost per year)=1950000- 4950 (base product)= 10809300
Units full capacity= 208593 The total in the year 1995 was354,750 of blood transfusion with 84% of no satisfaction with alternative products we suppose that with 70% of satisfaction the number could be increase and the units of sales could also go up.
The...